Anti-prion ASOs prolong survival in mice with prion disease
From: Prion protein lowering is a disease-modifying therapy across prion disease stages, strains and endpoints
Eric Vallabh Minikel et al., 2019 Nucleic Acids Research, 2020, Vol. 48, No. 19 10615–10631